UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer

Frontiers in oncology, 2020-09, Vol.10, p.1167-1167

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS9107-TPS9107

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib

Cancer chemotherapy and pharmacology, 2014-02, Vol.73 (2), p.299-307

2014

Link zum Volltext

Verfügbarkeit prüfen

Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e18026-e18026

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospective correlative study of FDG-PET SUV and proteomic profile (VeriStrat) of non-small cell lung cancer patients treated with erlotinib

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e18096-e18096

2012

Link zum Volltext

Verfügbarkeit prüfen

Combined regimen of cisplatin, doxorubicin, and α-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the italian group on rare tumors (GITR) and the italian lung cancer task force (FONICAP)

Cancer, 2001-08, Vol.92 (3), p.650-656

2001

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study

Investigational new drugs, 2007-02, Vol.25 (1), p.57-62

2007

Link zum Volltext

Verfügbarkeit prüfen

NON-SMALL-CELL LUNG CANCER PATIENTS UNSUITABLE FOR FIRST-LINE CHEMOTHERAPY: A NEW CATEGORY OF PATIENTS FOR CLINICAL STUDIES?

Journal of the American Geriatrics Society (JAGS), 2005-06, Vol.53 (6), p.1078-1079

2005

Link zum Volltext

Verfügbarkeit prüfen

P-32 Feasibility of combination of cisplatin (C) and gemcitabine (G) in non-small cell lung cancer (NSCLC): Analysis of dose-intensity (DI) and compliance of four different schedules

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S99-S99

2003

Link zum Volltext

Verfügbarkeit prüfen

Short Schedule of Cisplatin and Vinorelbine: A Dose-Finding Study in Non-Small-Cell Lung Cancer

Oncology, 2006-01, Vol.71 (3-4), p.229-236

2006

Link zum Volltext

Verfügbarkeit prüfen

P-619 Analysis of responses to gefitinib (ZD 1839 Iressa TM) according to epidermal growth factor receptor (EGFR) expressed as staining intensity or percentage of immunoreactive cells

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S248-S249

2003

Link zum Volltext

Verfügbarkeit prüfen

P-4 Preliminary results of an intensified 3-day schedule of cisplatin (P) and vinorelbine (V) as induction treatment in prognostically unfavorable locally advanced non-small-cell lung cancer (LA-NSCLC)

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S92-S92

2003

Link zum Volltext

Verfügbarkeit prüfen

P-618 ZD 1839 (Iressa) in elderly patients with progressive pretreated non small cell lung cancer (NSCLC): Results at the Istituto clinico humanitas, Rozzano, Milano

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S248-S248

2003

Link zum Volltext

Verfügbarkeit prüfen

Primary diffuse malignant peritoneal mesothelioma: Case report and update of therapy

Journal of surgical oncology, 2000-09, Vol.75 (1), p.55-58

2000

Link zum Volltext

Verfügbarkeit prüfen

Lipomas of the large bowel

The European journal of surgery, 1996-11, Vol.162 (11), p.915-919

1996

Link zum Volltext

Verfügbarkeit prüfen

Combined regimen of cisplatin, doxorubicin, and α‐2b interferon in the treatment of advanced malignant pleural mesothelioma

Cancer, 2001-08, Vol.92 (3), p.650-656

2001

Link zum Volltext

Verfügbarkeit prüfen

Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma: A Phase II multicenter trial of the Italian group on rare tumors (GITR) and the italian lung cancer task force (FONICAP)

Cancer, 2001-08, Vol.92 (3), p.650-656

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment perspectives in advanced non-small cell lung cancer

Tumori, 2000-09, Vol.86 (5 Suppl 1), p.S36-41

2000

Link zum Volltext

Verfügbarkeit prüfen

Delayed Rectal Perforation by Retained Surgical Drain

The European journal of surgery, 1999-09, Vol.165 (8), p.811-812

Rosario Vecchio, Filippo Di Franco, Caterina Ranzani, Fiorenza Latteri, Marco Magnano, Emma Cacciola

1999

Link zum Volltext

Verfügbarkeit prüfen

Delayed rectal perforation by retained surgical drain

The European journal of surgery, 1999-08, Vol.165 (8), p.811-812

1999

Link zum Volltext

Verfügbarkeit prüfen

Stromal tumors of the small intestine. Retrospective analysis of 9 cases surgically treated

Chirurgia italiana, 2002-03, Vol.54 (2), p.133

2002

Link zum Volltext

Verfügbarkeit prüfen

Bladder Cancer

Practical Medical Oncology Textbook, p.775-790

Link zum Volltext

Verfügbarkeit prüfen

Delayed rectal perforation by retained surgical drain

European Journal of Surgery, 1999, Vol.165 (8), p.811-812

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(23)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(9)
Female
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Aged
(6)
Biological And Medical Sciences
(6)
Male
(6)
Medical Sciences
(6)
Middle Aged
(6)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Lung Neoplasms - Drug Therapy
(5)
Oncology
(5)
Chemotherapy
(4)
Immunotherapy
(4)
Tumors
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Carcinoma, Non-Small-Cell Lung - Pathology
(3)
Cisplatin
(3)
Lung Neoplasms - Pathology
(3)
Surgery
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer

Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib

Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study

Prospective correlative study of FDG-PET SUV and proteomic profile (VeriStrat) of non-small cell lung cancer patients treated with erlotinib

Combined regimen of cisplatin, doxorubicin, and α-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the italian group on rare tumors (GITR) and the italian lung cancer task force (FONICAP)

Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study

NON-SMALL-CELL LUNG CANCER PATIENTS UNSUITABLE FOR FIRST-LINE CHEMOTHERAPY: A NEW CATEGORY OF PATIENTS FOR CLINICAL STUDIES?

P-32 Feasibility of combination of cisplatin (C) and gemcitabine (G) in non-small cell lung cancer (NSCLC): Analysis of dose-intensity (DI) and compliance of four different schedules

Short Schedule of Cisplatin and Vinorelbine: A Dose-Finding Study in Non-Small-Cell Lung Cancer

P-619 Analysis of responses to gefitinib (ZD 1839 Iressa TM) according to epidermal growth factor receptor (EGFR) expressed as staining intensity or percentage of immunoreactive cells

P-4 Preliminary results of an intensified 3-day schedule of cisplatin (P) and vinorelbine (V) as induction treatment in prognostically unfavorable locally advanced non-small-cell lung cancer (LA-NSCLC)

P-618 ZD 1839 (Iressa) in elderly patients with progressive pretreated non small cell lung cancer (NSCLC): Results at the Istituto clinico humanitas, Rozzano, Milano

Primary diffuse malignant peritoneal mesothelioma: Case report and update of therapy

Lipomas of the large bowel

Combined regimen of cisplatin, doxorubicin, and α‐2b interferon in the treatment of advanced malignant pleural mesothelioma

Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma: A Phase II multicenter trial of the Italian group on rare tumors (GITR) and the italian lung cancer task force (FONICAP)

Treatment perspectives in advanced non-small cell lung cancer

Delayed Rectal Perforation by Retained Surgical Drain

Delayed rectal perforation by retained surgical drain

Stromal tumors of the small intestine. Retrospective analysis of 9 cases surgically treated

Bladder Cancer

Delayed rectal perforation by retained surgical drain

Suchergebnisse filtern